Lilly Tirzepatide Mounjaro Injection

10,000.00 - 14,000.00 / Box

4 Box (MOQ)

Business Type Manufacturer, Exporter, Supplier, Retailer, Wholesaler, Trader, Distributor, Importer, Buying House
Type Lilly Tirzepatide Mounjaro 2.5mg Injection
Material Injection
Payment Terms L/C, D/A, D/P, T/T, Western Union, Other
Click to view more

Preferred Buyer From

Location Worldwide

Product Details

Delivery Time
2 - 3 days

Product Description


 


Eli Lilly and Company is proud to announce that the U.S. Food and Drug Administration (FDA) approved Mounjaro™ (tirzepatide) injection for the treatment of adults with type 2 diabetes as an adjunct to diet and exercise. The approval of Mounjaro represents the first new class of diabetes medication introduced in nearly a decade.Mounjaro is the first and only approved once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is a single molecule that targets the body's receptors for GIP and GLP-1, which are natural incretin hormones. Results from the global phase 3 SURPASS program supported this approval.

Yes! I am interested

Looking for "Lilly Tirzepatide Mounjaro Injection" ?

Box

Explore More Products


Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us